New data presented at AACR supports adding pembrolizumab before and after surgery in patients with newly diagnosed locally ...

Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or ...

A group of scientists from the University of the Philippines (UP) Diliman has identified potential biomarkers for lung cancer ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

Compromised antigen presentation ranks among the top mechanisms that render cancers non-immunogenic (non-responsive to immune ...

In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing ...

This discovery opens the door for new kinds of treatments. If doctors could develop drugs that block CD9 or stop cancer cells ...

CI denotes confidence interval, and LUAD lung adenocarcinoma ... lower than the cohort average for each cell type) in the lung tumor microenvironment. Panel E shows a bar plot representing ...

In advanced head and neck squamous cell carcinoma, evorpacept and Keytruda didn’t meet the primary endpoints of the ASPEN-03 ...